Results 91 to 100 of about 5,736 (192)

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial

, 2002
Deferiprone has been suggested as an effective oral chelation therapy for thalassemia major. To assess its clinical efficacy, we compared deferiprone with deferoxamine in a large multicenter randomized clinical trial.
A. Mangiagli, P. Cianciulli, G. D'Amico, A. Maggio, A. Morabito, M. Capra, M. Rizzo, C. Ciaccio, D. G. D'Ascola, G. Garozzo, G. Quarta, M. Midiri, R. Malizia, C. Magnano, F. Di Gregorio, A. Rizzo   +15 more
core   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Deferiprone: new environmental perspectives. Insights into its sequestering ability vs. different metal cations

Ecotoxicology and Environmental Safety
Deferiprone, generally, is considered an important chelating agent for Fe3+ overload. From a literature data analysis, a lack of information on the interaction of this molecule toward a series of metal cations emerged, inducing to fill out the topic. The
Anna Irto, Francesco Crea, Marco Milone, Giuseppe Gattuso, Clemente Bretti, Concetta De Stefano, Rosalia Maria Cigala   +6 more
doaj   +1 more source

Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial.

, 2014
We conducted a 6-month, randomized, double-blind, placebo-controlled study to assess safety, tolerability, and efficacy of deferiprone in Friedreich ataxia (FRDA).JOURNAL ARTICLESCOPUS: ar.jSCOPUS: ar.jFLWINinfo:eu-repo/semantics ...
Pandolfo, Massimo, Mark A. Tarnopolsky, Mariotti, Caterina, Geneieve Tai, Fernando Tricta, Sanz-Gallego, Irene, Michael Spino, Spino, Michael, Franco Taroni, Taroni, Franco, Delatycki, Martin B, Caterina Mariotti, Le Quan Sang, Kim Hanh, Kim Hanh Le Quan Sang, Tai, Geneieve, Tricta, Fernando, Irene Sanz‐Gallego, Munnich, Arnold, Arnold Munnich, Tarnopolsky, Mark A, Javier Arpa, Massimo Pandolfo, Arpa, Javier, Martin B. Delatycki   +23 more
core   +1 more source

Solubility of Deferiprone in Non-Aqueous Mixtures of Polyethylene Glycol 400 and 1-Propanol at 293.2–323.2 K

Liquids
Utilizing the shake-flask technique under atmospheric pressure (101 kPa) within the temperature range of 293.2 to 313.2 K, the experimental solubility and density values of deferiprone were determined in binary mixtures of polyethylene glycol 400 and 1 ...
Homa Rezaei, Abolghasem Jouyban
doaj   +1 more source

Datasheet1_Chitogel with deferiprone following endoscopic sinus surgery: improved wound healing and microbiome.pdf

BackgroundAdhesion formation, sinus ostial narrowing, and presence of pathogenic bacteria are associated with poor outcomes following endoscopic sinus surgery (ESS) for chronic rhinosinusitis.
Erich Vyskocil (4739916), Anna Megow (18300424), Yazeed Alsuliman (18300427), Clare Cooksley (4169461), George Bouras (835677), William Murphy (308098), Sarah Vreugde (541061), Peter-John Wormald (541063)   +7 more
core   +1 more source

Bioequivalence Study of Deferiprone In Healthy Pakistani Volunteers [PDF]

, 2012
The study was conducted to evaluate the bioequivalence of deferiprone 500 mg with innovator drug in Pakistani men. Twenty four healthy volunteers were enrolled in this study.
Abbas, Mateen, Waheed, Naila, Ashraf, Muhammad, Khan, Abdul M., Riffat, Sualeha, Amin, Sadia   +5 more
core  

Novel antidepressant-like properties of the iron chelator deferiprone in the 5-HTT knock-out mouse model of depression

, 2021
© 2021 Volkan UzungilCurrent therapeutics for major depressive disorder (MDD) have limited utility due to their extensive side effect profiles and limited efficacy.
Uzungil, Volkan
core  

An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload

, 2019
Introduction: Congenital hemoglobinopathies represent the most severe forms of anemia in Europe requiring treatment that include regular blood transfusions and iron chelators administered alone or in combination.
Mariagrazia Felisi (4001651), Viviana Giannuzzi (4001669), Rosa Conte (4001675), Fedele Bonifazi (4001648), Adriana Ceci (4001666), Donato Bonifazi (4001660), Antonella Didio (6739616)   +6 more
core   +1 more source